Protocol for CRISPR-Cas9 gene editing of murine neutrophils for in vitro and in vivo mechanistic studies
Year: 2026
Type: article
Abstract: Neutrophils’ short lifespan and resistance to genetic manipulation have limited mechanistic interrogation of gene-specific functions in these cells. Here, we present a protocol for gene targeting in murine neutrophil-lineage cells using two complementary CRISPR-Cas9-based strategies. First, we describe steps for an ER-Hoxb8-based system for scalable gain- and loss-of-function studies. We then detail procedures for a Lineage− Sca-1+ cKit+ (LSK) progenitor cell-based hematopoietic stem and progenitor cell-targeting strategy for stable genetic perturbation of endogenous neutrophils. For complete information on the generation and use of this protocol, please refer to Bolli et al. 1 1. Bolli, E. ∙ Wirapati, P. ∙ Hicham, M. ... CCL3 is produced by aged neutrophils across cancers and promotes tumor growth Cancer Cell. 2026; 44 :624-640.e12 Full Text Full Text (PDF) Scopus (8) PubMed Google Scholar
Source: STAR Protocols
Institutions: University of Calgary, Karolinska University Hospital, Science for Life Laboratory, Karolinska Institutet, Broad Institute, Harvard University, Massachusetts General Hospital, Massachusetts Institute of Technology, University of Geneva, University Hospital of Geneva, Ludwig Cancer Research, Swiss Cancer Center Léman
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: gold
Estimated APC paid: $1,550
OpenAlex ID: W7234618452
